Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PolyPid Ltd. - Ordinary Shares (NQ:PYPD)

3.390 +0.040 (+1.19%)
Streaming Delayed Price Updated: 2:56 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PolyPid Ltd. - Ordinary Shares

< Previous 1 2 3 Next >
An Overlooked Crisis in Hospitals Could Be Pharma’s Next Great Opportunity
Via AB Newswire
These stocks are moving in today's pre-market session
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Cisco To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
A Look Ahead: PolyPid's Earnings Forecast
 
Via Benzinga
Earnings Scheduled For February 12, 2025
 
Via Benzinga
Earnings Scheduled For November 13, 2024
 
Via Benzinga
PolyPid's Earnings: A Preview
 
Via Benzinga
POLYPID LTD (NASDAQ:PYPD) Reports Q2 2025 Results with Mixed Market Reaction Despite Positive Phase 3 D-PLEX₁₀₀ Data
PolyPid reports Q2 2025 results with positive Phase 3 data for D-PLEX₁₀₀, but EPS miss and no revenue. Stock dips slightly pre-market. 
Via Chartmill
PolyPid’s Game-Changing 60-Day GLP-1 Platform Could Disrupt $100B Weight Loss Market
Via AB Newswire
With Fresh Funding and Strong Phase 3 Data, PolyPid Advances Towards FDA Approval
Surgical infection prevention breakthrough demonstrates 58% infection reduction as company secures funding through regulatory approval (NASDAQ:PYPD)* 
Via News Direct
These stocks have an unusual volume in today's session
Volume analysis on 2025-06-10: stocks with an unusual volume in today's session. 
Via Chartmill
Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial
PolyPid's D-PLEX100 met all key endpoints in a Phase 3 trial, showing a 38% drop in infection or death after colorectal surgery vs. standard care. 
Via Benzinga
PYPD Stock Earnings: PolyPid Beats EPS for Q2 2024
PYPD stock results show that PolyPid beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
PYPD Stock Earnings: PolyPid Beats EPS for Q1 2024
PYPD stock results show that PolyPid beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For August 13, 2025
 
Via Benzinga
Earnings Scheduled For February 14, 2024
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion. 
Via Benzinga
Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
 
Via Benzinga
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
Via ACCESS Newswire
PolyPid Ltd. (NASDAQ: PYPD) Near the Top of Equities by Percentage Gain on 1/5
Via Investor Brand Network
PolyPid's Earnings: A Preview
 
Via Benzinga
Earnings Scheduled For May 14, 2025
 
Via Benzinga
PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025
Via ACCESS Newswire
Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday
 
Via Benzinga
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
 
Via Benzinga
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Applied Therapeutics, Inc. 
Via Benzinga
Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023
 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 369 companies hit new 52-week lows. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.